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Abstract
Backgroundr Abnorma旭 c旭ot structure has been identified in patients with thrombotic 
disorderss Anticoagu旭ant therapy offers c旭ear benefits for thrombosis prevention and 
treatment by reducing b旭ood c旭ot formation and sizeq neverthe旭essp there are 旭imited 
data on the effects of different anticoagu旭antsp where c旭otting is initiated with differ-
ent triggersp on c旭ot structures
Objectivesr Our aim was to investigate the effects of vitamin K antagonists and fac-
tor Xa inhibitors on c旭ot structures
Methodsr C旭ots from poo旭ed p旭asma spiked with rivaroxabanp apixabanp or enoxapa-
rinp as we旭旭 as p旭asma from patients on warfarinp were compared to p旭asma without 
anticoagu旭ations The kinetic profi旭e of po旭ymerizing c旭ots was obtained by turbidityp 
fiber density was determined by confoca旭 microscopyp c旭ot pore size was investigated 
by permeationp and fiber size was ana旭yzed using scanning e旭ectron microscopys 
C旭otting agonist was either tissue factor or thrombins
Resu旭tsr Fo旭旭owing c旭otting with tissue factorp a旭旭 anticoagu旭ated c旭ots had a signifi-
cant旭y increased 旭ag timep with the exception of enoxaparins Rivaroxaban addition-
a旭旭y 旭ed to significant旭y 旭ess dense and more permeab旭e c旭otsp with thicker fiberss In 
contrastp turbidity ana旭ysis fo旭旭owing initiation with thrombin showed few effects of 
anticoagu旭ationp with on旭y enoxaparin 旭eading to a pro旭onged 旭ag times Enoxaparin 
c旭ots made with thrombin were 旭ess dense and more permeab旭es
Conc旭usionr Our resu旭ts show that anticoagu旭ants modu旭ate c旭ot structure particu-
旭ar旭y when induced by tissue factorp most 旭ike旭y due to reduction of thrombin gen-
erations We propose that the effects of different anticoagu旭ants cou旭d be assessed 
with a g旭oba旭 c旭ot structure measurement such as permeation or turbidityp providing 
information on c旭ot phenotypes
K E Y W O R D S
anticoagu旭antsp factor Xa inhibitorsp fibrin c旭otp LMWHp warfarin
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Essentia旭s
ｨ Anticoagu旭ant therapies are associated with different b旭eeding riskss
ｨ There are 旭imited data on the effects of anticoagu旭ants on fibrin c旭ot structures
ｨ Initiation with tissue factor but not thrombin revea旭s effects of direct ora旭 anticoagu旭ants on c旭ot structures
ｨ C旭ot structure cou旭d be used as a g旭oba旭 test for anticoagu旭ant activitys
ゲ科 |科INTRODUCTION
Thrombosis is a major contributor to g旭oba旭 disease burdenp being 
a serious and 旭etha旭 component of cardiovascu旭ar diseases such as 
ischemic heart diseasep strokep and venous thromboembo旭ismsゲpゴ 
Thromboembo旭ic conditions accounted for one in four deaths 
wor旭dwide in ゴグゲグ and remain the 旭eading cause of death around 
the world.ザ､葦 Anticoagu旭ants decrease b旭ood c旭ot formation by tar-
geting and modu旭ating the coagu旭ation pathway and arep thereforep 
common旭y administered to prevent and treat thromboembo旭ic disor-
derss7 Howeverp a旭旭 anticoagu旭ant drugs to date are associated with 
a certain b旭eeding risk that needs to be considered in the decision of 
anticoagu旭ation administrations芦pゾ
Conventiona旭旭yp individua旭s with thrombosis received a com-
bination of 旭ow､mo旭ecu旭ar､weight heparins ｪLMWHsｫp fo旭旭owed by 
vitamin K antagonists ｪVKAsｫp particu旭ar旭y warfarins Direct ora旭 an-
ticoagu旭ants ｪDOACsｫp which direct旭y inhibit thrombin or activated 
factor X ｪFXaｫp have more recent旭y been deve旭opeds Un旭ike warfarinp 
DOACs can be administered at fixed dosesp thus reducing the num-
ber of hospita旭 visits for drug monitoringsゲグpゲゲ
Previous studies have shown that fibrin c旭ot structure is abnor-
ma旭 in individua旭s with thrombotic conditionsp and individua旭s with 
with postthrombotic syndrome and recurrent venous thromboem-
bo旭ism ｪVTEｫ patients have denser c旭ots with thinner fibers that are 
resistant to fibrino旭ysiss12 In additionp c旭ots from individua旭s with 
deep vein thrombosis were a旭so shown to be thinnerp 旭ess porousp 
and more resistant to 旭ysiss13 These studies indicate that abnorma旭 
fibrin c旭ot structure is associated with patients with thrombotic dis-
orderss Anticoagu旭antsp inc旭uding warfarin and DOACsp have been 
shown to a旭ter fibrin c旭ot structure by increasing c旭ot porosity and 
a旭tering c旭ot densitysゲゲpゲジpゲズ Direct thrombin inhibitors have a旭so been 
shown to de旭ay thrombin generation and increase c旭ot permeabi旭-
ity.ゲ葦pゲゼ In additionp anticoagu旭ants have been shown to de旭ay c旭otting 
旭ag time and increase the efficiency of c旭ot 旭ysissゲゲpゲ芦､ゴゲ
The effects of anticoagu旭ants on c旭ot structure have been 
previous旭y investigated using thrombinゲゴpゲザpゲズpゴゴ or tissue factor 
ｪTFｫpゲゲpゲジpゲ葦pゲゼpゲゾ､ゴゲpゴザpゴジ as we旭旭 as TF､bearing ce旭旭sゴズpゴ葦 as c旭otting ago-
nistss In additionp thrombus growth and fibrin distribution patternsp 
re旭ated to c旭ot stabi旭ityp have a旭so been studied with TF､bearing co旭-
旭agen surfacessゴゼpゴ芦 TF has been reported to better ref旭ect effects of 
VKAs on c旭ot density and permeabi旭itysゴゾ In this studyp we compared 
c旭ot structure in p旭asma from individua旭s on warfarinp poo旭ed p旭asma 
ｪPPｫ spiked with the direct FXa inhibitors rivaroxaban and apixabanp 
and PP spiked with the indirect FXa inhibitor enoxaparinp to PP con-
tro旭 using a range of sensitive methods that ana旭yze c旭ot densityp 
porosityp and fiber thicknesss We thus used a comprehensive set 
of c旭ot structure ana旭ysis methods to direct旭y compare the effects 
of VKAs and indirect｠direct FXa inhibitors on fibrin c旭ot structure 
when c旭otting was triggered with either thrombin or TFs
ゴ科 |科MATERIALS AND METHODS
ゴsゲ科|科Materia旭s
A旭exa F旭uor ズゾジ･fibrinogen ｪThermo Fisher Scientificp A旭trinchamp 
UKｫ was reconstituted in doub旭e､disti旭旭ed water ｪddH2Oｫ to ゴsズ mg｠
mLs Human thrombin ｪMerck Diagnosticsp Darmstadtp Germanyｫ was 
reconstituted to ゴズグ U｠mL in ddH2O and stored at ･芦グﾀCs Di旭utions 
were performed in グsグズM Tris､Basep グsゲ M NaC旭p pH ゼsジ ｪTBSｫs PPP､
Reagent ｪStagop Parsippanyp NJp USAｫ was reconstituted in ゲ mL of 
ddH2O to ザグ pM of TF and ゴジ µM phospho旭ipidss A旭旭 other chemica旭s 
were obtained from Sigma､A旭drich ｪSts Louisp MOp USAｫ un旭ess stated 
otherwises
Apixaban and rivaroxaban powder ｪMedChemExpressp Princetonp 
NJp USAｫ were initia旭旭y reconstituted in dimethy旭 su旭foxide and sub-
sequent旭y di旭uted ゲrゾ in deionized waters They were spiked in nor-
ma旭､poo旭ed p旭asma ｪNPPｫ at concentrations of apixaban ゲゴ芦 ng｠mL 
and rivaroxaban ゲゼジ ng｠mL both at therapeutic 旭eve旭ss Enoxaparin 
sodium ｪC旭exaneｫ was spiked in NPP at concentration グsザズ U｠mLp 
that isp equiva旭ent to a prophy旭actic doses
ゴsゴ科|科B旭ood co旭旭ection
A poo旭 of p旭asma from ザズズ outpatient c旭inic ｪpreoperative assess-
mentｫ patients with norma旭 internationa旭 norma旭ized ratio ｪINRｫ｠
activated partia旭 thrombop旭astin time was obtained from an-
onymized norma旭 citrated samp旭es ｪVacuettep Greiner Bio､Onep 
Monroep NC USAｫ and ana旭yzed in the Coagu旭ation Laboratory 
at Mater Dei Hospita旭 ｪMsidap Ma旭taｫs As our poo旭ed p旭asma was 
obtained from individua旭s undergoing a wide range of surgica旭 
proceduresp it inc旭udes a mixture of individua旭s with and with-
out under旭ying hea旭th conditionss A旭旭 samp旭es underwent doub旭e 
centrifugation ｪゲグ minutes at ゴズググ g twicep using the Eppendorf 
Centrifuge ズ芦ゲグp Eppendorf AGp Germanyｫ to obtain p旭ate旭et､poor 
p旭asma ｪPPPｫp and they were frozen at ┋芦グﾀCs They were subse-
quent旭y spiked with apixabanp rivaroxabanp and enoxaparin at the 
desired concentrationss Warfarinized PPP was co旭旭ected from an-
onymized outpatientsv samp旭es receiving warfarin therapys There 
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were two poo旭s of warfarinized p旭asmap that isp INR ゴsゴ ｪsamp旭es 
of patients with INR ゴ､ザｫ and INR ジsゲ ｪsamp旭es from patients with 
INR ジ､葦ｫ to represent therapeutic and supratherapeutic INRp re-
spective旭ys They were prepared fo旭旭owing the same protoco旭 of 
the p旭asma spiked with anticoagu旭ants and underwent an identi-
ca旭 number of freeze､thaw cyc旭ess Frozen anticoagu旭ated samp旭es 
were shipped to Leeds and Sheffie旭d on dry ices Poo旭ed p旭asma 
ｪPPｫ with a measured fibrinogen concentration of ジs葦ジ mg｠mL 
was used as references PP from individua旭s on warfarin INR ゴsゴ 
ｪザs芦グ mg｠mL fibrinogenｫ and p旭asma from individua旭s on warfarin 
INR ジsゲ ｪジsザゲ mg｠mL fibrinogenｫ were chosenp as their fibrinogen 
旭eve旭s were most simi旭ar to PPs
The prothrombin time｠INR assayp fibrinogen concentrationsp and 
the anti､Xa assay for enoxaparin were performed using an ACL TOP 
ズググ ana旭yzer ｪInstrumentation Laboratoryp Bedfordp MAp USAｫ and 
the fo旭旭owing reagentsr HemosIL RecombiP旭asTin ゴGp HemosIL QFA 
Thrombin ｪBovineｫp and HemosIL Liquid Anti､Xa kit ｪInstrumentation 
Laboratoryｫs The anti､Xa assays for apixaban and rivaroxaban were 
performed in the Coagu旭ation Laboratory at the Roya旭 Ha旭旭amshire 
Hospita旭p using the ana旭yser Sysmex CS､ズゲググ ｪSiemens Hea旭thcare 
Diagnostics Products GmbHp Marburgp Germanyｫ and the Biophen 
DiXa旭 kit ｪHyphen BioMedp Neuvi旭旭e､sur､Oisep Franceｫ with specific 
ca旭ibratorss
Fina旭旭yp norma旭 poo旭ed p旭ate旭et､poor p旭asma ｪNPPｫ used in some 
of the supp旭ementary experiments was obtained from ザグ hea旭thy 
individua旭s at the Leeds Institute of Cardiovascu旭ar and Metabo旭ic 
Medicinep with a fibrinogen concentration of ザsジ mg｠mLs
ゴsザ科|科Thromboe旭astography
Thromboe旭astography ｪTEGｫ was performed at Mater Dei Hospita旭 
ｪMsidap Ma旭taｫ on citrated PPPp using a TEGズグググ ｪThromboe旭astograph 
Hemostasis Ana旭yserp Haemoscopep Haemonetics Corporationp 
Braintreep MAp USAｫ with dedicated software ｪTEG Ana旭ytica旭 
Software version ジsゴsザp Haemoscopep Haemonetics Corporationｫs
The native TEG used citrated PPP ザザグ µ旭 and CaC旭2 0.2M 30 µl 
ｪwithout the addition of a c旭otting trigger such as thrombin or TFｫ 
and was performed in dup旭icatep using the two channe旭s provideds 
The resu旭ts were expressed as mean ± SDs
ゴsジ科|科Turbidity ana旭ysis of po旭ymerizing fibrin c旭ots
The kinetic profi旭e of po旭ymerizing fibrin c旭ots was investigated by 
turbidityp using a standardized protoco旭 as previous旭y describeds30 In 
briefp p旭asma was di旭uted to a fina旭 ratio of ゲ in 葦 in TBS and 旭oaded 
onto ザ芦ジ､we旭旭 p旭ates ｪThermo Fisher Scientificp A旭trinchamp UKｫ in 
trip旭icatess An activation mixture of ズ mM CaC旭2 ｪfina旭 concentrationｫ 
and either tissue factor ｪfina旭 concentrationp ゲ pMｫ or thrombin ｪfina旭 
concentrationp グsゲ U｠mLｫ was added to initiate c旭ottings Thrombin 
concentration was chosen fo旭旭owing optimization for this and other 
methods describeds TF concentration used in a旭旭 methods was chosen 
to ref旭ect the 旭ow TF concentration used in the ca旭ibrated automated 
thrombogram thrombin generation assays Changes in absorbance 
ｪor optica旭 densityｫ were measured at ザジグ nm every ゲゼ seconds for 
ゲ hour at ザゼﾀC using a Powerwave microtiter､p旭ate reader ｪBio､Tekp 
Swindonp UKｫs The parameters ana旭yzed from the turbidity profi旭e 
were 旭ag time to initiation of po旭ymerizationp maximum absorbance 
ｪan indicator of fiber diameterｫ and average rate of c旭otting ｪbased 
on the rate between ゴズ鯵 and ゼズ鯵 c旭ottingｫs Turbidity experiments 
were performed in dup旭icate or trip旭icatep each with three technica旭 
rep旭icatess
ゴsズ科|科Laser scanning confoca旭 microscopy
P旭asma was di旭uted to a fina旭 ratio of ゲ in 葦 with TBS and spiked with 
A旭exa F旭uor ズゾジ 旭abe旭ed fibrinogen at ズグ µg｠mL fina旭 concentrations 
C旭otting was triggered by the addition of ズ mM CaC旭2 ｪfina旭 concen-
trationｫ and either TF ｪfina旭 concentrationp ゲ pMｫ or thrombin ｪfina旭 
concentrationp グsゲ U｠mLｫs Once c旭otting was initiatedp the mixture 
was immediate旭y transferred to the channe旭 of an uncoated µ､S旭ide 
VI グsジ mm ｪIbidi GmbHp Gr士fe旭fingp Germanyｫp and p旭aced in a dark 
humidity chamber for ゴ hours at room temperature to a旭旭ow c旭ots to 
forms Images were obtained using a Zeiss LSM芦芦グ inverted micro-
scope with a ジグ× oi旭 immersion 旭enss Optica旭 z､stacks ｪジザ × 0.7 µmｫ 
were combined and f旭attened to show maximum intensitys Fiber den-
sity was determined by averaging the tota旭 number of fibers crossing 
an arbitrary straight 旭ine of fixed 旭ength ｪゴググ µmｫs Image processing 
and fiber counting were executed on ImageJ softwares Fibrin c旭ots 
were prepared in trip旭icatep and three density measurements were 
obtained per c旭ots
ゴs葦科|科C旭ot permeation
The c旭ot permeabi旭ity assay was adapted from a previous旭y described 
method.31 P旭asma samp旭es were di旭uted to a fina旭 ratio of ゲ in 芦s芦 
with TBSs C旭otting was initiated by the addition of an activation 
mixture containing ゲグ mM CaC旭2 ｪfina旭 concentrationｫ and either TF 
ｪfina旭 concentration ゲ pMｫ or thrombin ｪfina旭 concentrationp グsズ U｠
mLｫs Immediate旭y after initiation of c旭ottingp the mixture was trans-
ferred to the channe旭 of an Ibidi uncoated µ､S旭ide VI グsジ mmp then 
p旭aced in a humidity chamber for ゲ hour at room temperature to 
a旭旭ow c旭ots to forms A p旭astic syringe was connected to the we旭旭 cor-
responding to the channe旭 ho旭ding the c旭otp and a constant pressure 
was app旭ied by fi旭旭ing the syringe with TBS to a set height ｪジ cmｫs 
The c旭ots were washed in this manner for ザグ minutesp and f旭ow rates 
of buffer through the c旭ots were then measuredp by co旭旭ecting and 
weighing the buffer f旭ow､throughp every ゲグ minutes for ジグ minutess 
Vo旭ume ｪcorre旭ated to weightp assuming ゲg = ゲmLｫ of f旭ow､through 
over time was p旭otted and fitted by 旭inear regression ｪR2 ┕ グsゾゾｫs 
The permeation coefficient ｪKsp Darcy constantｫ was ca旭cu旭ated as 
previous旭y describeds32 The s旭ight旭y higher p旭asma di旭ution factorp 
thrombinp and ca旭cium concentrations were required to obtain a 
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measurab旭e f旭ow rate in the permeation assays Permeation experi-
ments were performed in trip旭icate or quadrup旭icates
ゴsゼ科|科Scanning e旭ectron microscopy
C旭ots for scanning e旭ectron microscopy ｪSEMｫ were prepared and 
imaged using a previous旭y described methods33 In briefp p旭asma was 
di旭uted ゲ in 葦 with TBSp and c旭otting was triggered by the addition 
of an activation mixture consisting of ゲグ mM CaC旭2 ｪfina旭 concen-
trationｫ and either TF ｪfina旭 concentrationp ゲ pMｫ or thrombin ｪfina旭 
concentrationp ゲ U｠mLｫs Immediate旭y fo旭旭owing c旭otting initiationp the 
mixture was transferred to pierced Eppendorf 旭ids and p旭aced in a 
humidity chamber for ゴ hours to a旭旭ow for c旭ot formations C旭ots were 
washed ザ times for ジグ minutes with sa旭ine so旭ution and fixed in ゴ鯵 
g旭utara旭dehyde overnights Once fixedp c旭ots were washed ザ times for 
ジグ minutes with sodium cacody旭ate buffer ｪズグ mM C2H12AsNaOズp 
pH ゼsジｫ and dehydrated in increasing concentrations of acetone 
ｪザグ鯵､ゲググ鯵ｫs C旭ots underwent critica旭 point drying with CO2 before 
being mounted onto stubs and sputter coated with ゲグ nm of iridium 
using a Cressington ゴグ芦 HR ｪCressington Scientific Instrumentsp 
Watfordp UKｫs Each c旭ot was formed in trip旭icate and imaged in three 
different areas at different magnificationsp ズグググ､ジグ グググ×ｫ using a 
Hitachi SU芦ゴザグ high､performance co旭d fie旭d emission SEM ｪChiyoda 
Corporationp Yokohomap Japanｫs Fibrin fiber thickness was ana旭yzed 
on images at ゴグ グググ× using ImageJs
ゴs芦科|科Statistica旭 Ana旭ysis
Data are presented as mean of at 旭east three rep旭icates ± SEp un-
旭ess otherwise stateds Differences between groups was determined 
by one､way ana旭ysis of variance or Kruska旭･Wa旭旭is testp fo旭旭owing 
Shapiro･Wi旭k test for norma旭ityp fo旭旭owed by Tukey･Kramer post 
hoc test or Dunn･Bonferroni to determine significant differences 
to contro旭 groups Data ana旭ysis was performed using OriginPro 
ゴグゲゼ｠ゴグゲ芦s P va旭ues<sグズ were considered to indicate statistica旭 
significances
ザ科 |科RESULTS
ザsゲ科|科Thromboe旭astography
C旭ot formation in the absence of a c旭otting trigger was ana旭ysed 
by native TEG ｪTab旭e ゲｫs The average R timep ref旭ective of the 旭ag 
time before the start of c旭ottingp was increased for PP spiked with 
the direct FXa inhibitor rivaroxaban ｪゲゾsズズ ± グsグゼ minutesq P < sグズｫ 
and enoxaparin ｪゴザsザズ ± グsザズ minutesq P < sグズｫp compared to con-
tro旭 ｪゲゴsゾゼ ± ザsゴ葦 minutesｫs C旭ot formation time ｪK timeｫ was a旭so 
increased for PP spiked with direct FXa inhibitors ｪrivaroxabanp 
ゼsズグ ± ゴsゲゴ minutesq and apixabanp 葦sググ ± ザsゲゲ minutesq P < sグズｫ 
and enoxaparin ｪゲゲsジグ ± 2.12 min; P < sグズｫp compared to con-
tro旭 ｪゴs葦ジ ± グsズズ minutesｫs The α､ang旭e corresponding to the tan-
gent 旭ine ang旭e from ゴ mm to ゴグ mm amp旭itude was narrower for 
PP spiked with rivaroxaban ｪゴゼsジグ ± ゼsゾゴﾀq P < sグズｫ and enoxaparin 
ｪゲゼsジグ ± グsゾゾﾀq P < sグズｫp compared to contro旭 ｪズゴsゴ ± ゼs葦ﾀｫs We a旭so 
observed a s旭ight increase in maximum amp旭itude ｪMAｫp ref旭ective 
of the u旭timate c旭ot strengthp for both warfarinized p旭asma samp旭es 
ｪINRp ゴsゴ ザゼs芦グ ± ゴs芦ザ mmq INRp ジsゲ ザ芦sグズ ± 1.34 mm; P < sグズｫ and 
a sma旭旭 reduction for PP spiked with rivaroxaban ｪゴ芦sジグ ± グsズゼ mmq 
P < sグズｫ and enoxaparin ｪゴ芦sゴグ ± グsゾゾ mmq P < sグズｫ re旭ative to contro旭 
ｪザゴsゾゴ ± ゲs芦葦 mmｫs
ザsゴ科|科C旭otting initiation with TF
Turbidity ana旭ysis of c旭ots formed with TF showed c旭ear differences 
in po旭ymerization ｪFigure ゲAｫs For instancep the 旭ag time was signifi-
cant旭y ｪP < sグググゲｫ 旭onger for warfarinized p旭asma samp旭es ｪゴ､fo旭d 
R time ｪminｫ K time ｪminｫ α､ang旭e ｪdegｫ MA ｪmmｫ
PP ゲゴsゾゼ ± ザsゴ葦 ゴs葦ジ ± グsズズ ズゴsジゼ ± ゼs葦ズ ザゴsゾゴ ± ゲs芦葦
Warfarinized PP
INR ゴsゴ
ゲグs芦ズ ± 1.34 ゴs芦グ ± 1.41 ズジsゲグ ± ゲズs芦ジ ザゼs芦グ ± ゴs芦ザ*
Warfarinized PP
INR ジsゲ
ゲ葦sゴズ ± 葦sグゲ ザsゼズ ± 1.34 ジゲs芦ズ ± ゲグs芦ゴ ザ芦sグズ ± 1.34*
PP + rivaroxaban
ｪゲゼジ ng｠mLｫ
ゲゾsズズ ± 0.07* ゼsズグ ± 2.12* 27.40 ± ゼsゾゴ* ゴ芦sジグ ± グsズゼ*
PP + apixaban
ｪゲゴ芦 ng｠mLｫ
ゲズs葦ズ ± ジsジズ 葦sググ ± 3.11* ザ葦sゾズ ± ゲゼs芦ゾ 33.40 ± 葦s葦ズ
PP + enoxaparin
ｪグsザズ U｠mLｫ
ゴザsザズ ± グsザズ* 11.40 ± 2.12* 17.40 ± グsゾゾ* ゴ芦sゴグ ± グsゾゾ*
Note: ±SDs
Abbreviationsr INRp internationa旭 norma旭ized ratioq MAp maximum amp旭itudeq PPp poo旭ed p旭ate旭et､
poor p旭asmaq TEGp thromboe旭astographys
*P < sグズ ｪMann､Whitney nonparametric U test for the comparison with PPｫs 
TA B L E  ゲ 科 TEG resu旭ts of ana旭ysis of 
reca旭cified p旭asma samp旭es containing 
different anticoagu旭antsp in the absence of 
c旭otting triggers
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and ゴsゾ､fo旭d for INR ゴsゴ and ジsゲp respective旭yｫp and p旭asma spiked 
with rivaroxaban ｪゴsザ､fo旭dｫ and apixaban ｪゲs芦､fo旭dｫs The de旭ay in c旭ot 
formation for these samp旭es suggests impaired protofibri旭 formation 
and are in agreement with the 旭onger K time obtained for FXa in-
hibitors in native TEG ｪTab旭e ゲｫs No change in 旭ag time was observed 
for p旭asma spiked with enoxaparin ｪFigure ゲBｫs Furthermorep there 
were no changes in maximum absorbance ｪMaxODｫ for p旭asma sam-
p旭es containing anticoagu旭ants compared to contro旭 ｪFigure ゲCｫs 
Warfarinized p旭asma at INR ジsゲ didp howeverp show a s旭ower rate of 
c旭otting ｪザsズ､fo旭dq P < sグズｫ ｪFigure ゲDｫs A s旭ower average rate indi-
cates that 旭onger time was required for c旭ots to achieve ゼズ鯵 c旭ot-
ting from ゴズ鯵p where MaxOD equates to ゲググ鯵 c旭ot formations Time 
to ズグ鯵 c旭otting and time to maximum rate of c旭otting ｪVmaxｫ fo旭旭ow 
the same pattern observed for 旭ag time for these samp旭es ｪFigure 
Sゲｫs A batch of ｪNPP from hea旭thy individua旭s was spiked with higher 
concentrations of enoxaparinp equiva旭ent to therapeutic dosages Lag 
time for NPP + グs葦 U｠mL enoxaparin was over ゴグ minutesp with nei-
ther NPP + ゲ U｠mL nor NPP + ゴ U｠mL c旭otting in ゲ hour ｪFigure SゴAｫs
ザsザ科|科C旭otting initiation with thrombin
Turbidity ana旭ysis of po旭ymerizing c旭otsp when c旭otting was initiated 
with thrombinp showed re旭ative旭y comparab旭e curve patterns for p旭asma 
samp旭es containing anticoagu旭ants compared to contro旭 ｪFigure ゴAｫs 
Interesting旭yp 旭ag time was ザ､fo旭d 旭onger ｪP < sグググゲｫ for p旭asma samp旭es 
spiked with enoxaparin compared to contro旭 ｪFigure ゴBｫp suggesting 
impaired protofibri旭 formations A旭though LMWHs have reduced abi旭-
ity to inhibit thrombin due to their sma旭旭er sizep34 the observed 旭onger 
旭ag time for p旭asma containing enoxaparin after addition of thrombin 
c旭ear旭y shows that this anticoagu旭ant sti旭旭 has an effect on thrombin ac-
tivitys This observation is a旭so in agreement with the changes observed 
F I G U R E  ゲ 科 Turbidity ana旭ysis parameters of po旭ymerizing c旭ots with tissue factors C旭otting of di旭uted p旭asma samp旭es was initiated 
with tissue factor and parameters of warfarinized p旭asma with internationa旭 norma旭ized ratio ゴsゴ ｪWarゴsゴｫ and ジsゲ ｪWarジsゲｫp and poo旭ed 
p旭asma ｪPPｫ spiked with rivaroxaban ｪRivaroxsｫp apixaban ｪApixsｫ or enoxaparin ｪEnoxsｫ were compared against PP contro旭s Turbidity curve of 
po旭ymerizing c旭otsq ｪAｫp error bars correspond to ± SE of two rep旭icatesp with three technica旭 rep旭icatess From turbidity curves c旭otting 旭ag 
time ｪBｫp maximum absorbance ｪMaxODｫ of fu旭旭y po旭ymerized c旭ots ｪCｫp and average rate of c旭ottingp defined by changes in absorbance over 
time ｪDｫp were determineds Data points correspond to individua旭 technica旭 rep旭icatess Error bars correspond to ± SEs ｰｰP < sグゲp ｰｰｰｰP < .0001. 
ODp optica旭 density
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by native TEG for the enoxaparin c旭ot ｪTab旭e ゲｫs Simi旭ar旭y to resu旭ts dis-
cussed above where c旭ots were formed with tissue factorp there were 
no changes in MaxOD for c旭ots formed with thrombin ｪFigure ゴCｫs 
Neverthe旭essp the average rate of c旭otting was ゴs葦､fo旭d ｪP < sグググゲｫ 
s旭ower for warfarinized p旭asma at INR ジsゲ ｪFigure ゴDｫs Time to ズグ鯵 
c旭otting and Vmax fo旭旭owed the same pattern observed for average rate 
of c旭otting and 旭ag time for these samp旭es ｪFigure Sザｫs NPP spiked with 
グs葦､ゴ U｠mL enoxaparin produced no detectab旭e c旭ots ｪFigure Sジｫs
ザsジ科|科Fiber density and permeabi旭ity fo旭旭owing 
c旭otting initiation with TF
The structura旭 architecture of fu旭旭y formed c旭otsp resu旭ting from 
c旭otting initiation with tissue factorp was investigated using 旭aser 
scanning confoca旭 microscopys There was a visua旭 decrease in fiber 
density for warfarinized p旭asma at INR ジsゲ and p旭asma contain-
ing rivaroxaban and apixaban ｪFigure ザCp Dp and Ep respective旭yｫ 
in comparison to contro旭 ｪFigure ザAｫs Moreoverp average fiber 
number per ゴググ µm was decreased for these samp旭es in re旭a-
tion to PP ｪ芦ゾ ± ゼｫp name旭yp warfarin INR ジsゲ ｪゼ芦 ± ゲゲp P < sグズｫp 
rivaroxaban ｪゼゲ ± ジp P < sグググゲｫp and apixaban ｪゼ芦 ± ゼp P < sグゲｫ 
ｪFigure ザGｫs Corresponding旭yp the permeation coefficient ｪKsｫ was 
increased for c旭ots of PP ｪゲs芦 ± グs葦 × 10┋芦 cm2ｫ spiked with rivar-
oxaban ｪザsゼ ± 0.3 × 10┋芦 cm2p P < sグゲｫ and apixaban ｪザsグ ± 0.2 × 10-
芦 cm2p P < sグズｫp indicating 旭arger c旭ot pore size for these samp旭es 
ｪFigure ザHｫs Three､by､three ti旭e scans show most旭y homogeneity of 
the structure of c旭ots ｪFigure Sズｫs The decrease in fiber density and 
increase in porosity observed for rivaroxaban c旭ots are in agree-
ment with the decreased MA observed for rivaroxaban c旭ots by 
F I G U R E  ゴ 科 Turbidity ana旭ysis parameters of po旭ymerizing c旭ots with thrombins C旭otting of di旭uted p旭asma samp旭es was initiated with 
thrombin and parameters of warfarinized p旭asma with internationa旭 norma旭ized ratio ゴsゴ ｪWarゴsゴｫ and ジsゲ ｪWarジsゲｫp and poo旭ed p旭asma ｪPPｫ 
spiked with rivaroxaban ｪRivaroxsｫp apixaban ｪApixsｫ or enoxaparin ｪEnoxsｫ were compared against PP contro旭s Turbidity curve of po旭ymerizing 
c旭otsq graph is a representation of one of four repeats ｪAｫp error bars correspond to ± SE of three technica旭 rep旭icatess From turbidity curves 
c旭otting 旭ag time ｪBｫp maximum absorbance ｪMaxODｫ of fu旭旭y po旭ymerized c旭ots ｪCｫp and average rate of c旭ottingp defined by changes in 
absorbance over time ｪDｫp were determineds Each data point represents the average of three technica旭 rep旭icatess Error bars correspond 
to ± SEs ｰｰｰP < sググゲp ｰｰｰｰP < sグググゲs ODp optica旭 density
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native TEG ｪTab旭e ゲｫs C旭ots from p旭asma containing higher concen-
trations of enoxaparinp name旭yp グs葦 U｠mL ｪゼsザ ± 0.1 × 10､芦 cm2ｫ and 
ゲ U｠mL ｪ芦sグ ± 0.2 × 10┋芦 cm2ｫ a旭so had increased ｪP < sグズｫ pore size 
compared to contro旭 ｪザsゼ ± グsズ × 10┋芦 cm2ｫ ｪFigure SゴBｫs A higher 
Ks va旭ue was a旭so observed for NPP containing ゴ U｠mL of enoxa-
parin ｪゲゲsグ × 10┋芦 cm2q Figure SゴBｫq howeverp on旭y a sing旭e va旭ue 
was obtained as c旭ots from further repeats did not withstand the 
constant f旭ows Confoca旭 images of c旭ots containing グs葦 U｠mL enoxa-
parin confirmed a 旭ooser structure and decreased fiber number per 
200 µm ｪザ葦 ± ゲグｫ when compared to contro旭 ｪゾザ ± 2; P < .0001; 
Figure SゴCｫp with higher concentrations of enoxaparin producing 
no visib旭e c旭otss
F I G U R E  ザ 科 Fibrin fiber density and porosity of fu旭旭y formed c旭ots fo旭旭owing c旭otting with tissue factors Confoca旭 microscopy images of 
poo旭ed p旭asma ｪPPｫ ｪAｫp warfarin internationa旭 norma旭ized ratio ｪINRｫ ゴsゴ ｪBｫp warfarin INR ジsゲ ｪCｫp PP + rivaroxaban ｪDｫp PP + apixaban ｪEｫp and 
PP + enoxaparin ｪFｫ were used to ca旭cu旭ate fibrin fiber density ｪGｫs Images are a representation of one of three repeatsp each imaged in three 
different areas of the c旭ots Each data point corresponds to individua旭 measurements of three rep旭icatess Sca旭e bar represents ズグ μms Fibrin 
c旭ot porosity ｪHｫ was determined by the permeation coefficient ｪKsｫp where higher Ks va旭ues indicate a more porous fibrin fiber networkp and 
旭ower Ks va旭ues suggest a 旭ess porous fibrin fiber networks Each data point corresponds to one of three rep旭icatess Error bars correspond 
to ± SEs ｰP < sグズp ｰｰP < sグゲpー ｰｰｰP < .0001
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ザsズ科|科Fiber density and permeabi旭ity fo旭旭owing 
c旭otting initiation with thrombin
Fu旭旭y formed c旭ots produced with thrombin were a旭so studied by 
旭aser scanning microscopys C旭ots of warfarinized p旭asma ｪFigure ジB 
and Cｫ were visua旭旭y denser than contro旭 ｪFigure ジAｫs In additionp 
p旭asma spiked with enoxaparin formed visua旭旭y 旭ess dense c旭ots 
ｪFigure ジFｫs These visua旭 observations corre旭ated to the average fiber 
number in 200 µmp where warfarinized p旭asma samp旭esp INR ゴsゴ 
ｪゼズ ± 2; P < sグゲｫ and INR ジsゲ ｪゼゼ ± ゾq P < sグズｫp had a higher average 
fiber count than PP ｪ葦ジ ± 葦ｫ and enoxaparin､spiked p旭asma ｪジズ ± ゲズq 
P < sグゲｫ ｪFigure ジGｫs Againp ザ × ザ ti旭e scans showed homogeneity 
F I G U R E  ジ 科 Fibrin fiber density and porosity of fu旭旭y formed c旭ots fo旭旭owing c旭otting with thrombins Confoca旭 microscopy images of poo旭ed 
p旭asma ｪPPｫ ｪAｫp warfarin internationa旭 norma旭ized ratio ｪINRｫ ゴsゴ ｪBｫp warfarin INR ジsゲ ｪCｫp PP + rivaroxaban ｪDｫp PP + apixaban ｪEｫp and 
PP + enoxaparin ｪFｫ were used to ca旭cu旭ate fibrin fiber density ｪGｫs Images are a representation of one of three repeatsp each imaged in three 
different areas of the c旭ots Each data point corresponds to individua旭 measurements of three rep旭icatess Sca旭e bar represents ズグ μms Fibrin 
c旭ot porosity ｪHｫ was determined by the permeation coefficient ｪKsｫp where higher Ks va旭ues indicate a more porous fibrin fiber networkp 
and 旭ower Ks va旭ues suggest a 旭ess porous fibrin fiber networks Each data point corresponds to one of five rep旭icatess Error bars correspond 
to ± SEs ｰP < sグズp ｰｰP < .01
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of a旭旭 c旭otsp exc旭uding enoxaparin c旭otsp which present a heteroge-
neous fibrin distribution ｪFigure S葦ｫs The fiber density fo旭旭ows the 
same trend as the MA resu旭ts obtained by native TEG ｪTab旭e ゲｫs 
Moreoverp c旭ots of p旭asma containing enoxaparin had increased Ks 
ｪズs葦 ± グsゾ × 10┋芦 cm2; P < sグゲｫ when thrombin was used as a trig-
gerp corre旭ating to 旭arger pore size in these c旭ots compared to contro旭 
ｪザsズ ± グsゾ × 10┋芦 cm2ｫ ｪFigure ジHｫs Permeation data and confoca旭 im-
ages cou旭d not be obtained for NPP spiked with グs葦､ゴ U｠mL enoxa-
parinp as no c旭ots were formed at these concentrationss
ザs葦科|科Fiber size fo旭旭owing c旭otting initiation with 
TF or thrombin
Fina旭旭yp we used SEM to ana旭yze fibrin fiber diameterss SEM images of 
fu旭旭y formed c旭otsp where TF was used as the c旭otting triggerp showed 
visua旭旭y 旭ess dense c旭ots formed with warfarinized p旭asma INR ジsゲ 
and p旭asma spiked with rivaroxaban and apixabanp when compared 
to contro旭 ｪFigure ズA､Fｫs These observations corroborate the fiber 
density data obtained from 旭aser confoca旭 microscopy imagesp de-
scribed above ｪFigure ザGｫs Moreoverp SEM images from c旭ots formed 
fo旭旭owing c旭otting with thrombin a旭so showed the same pattern 
determined by the average fiber counts of the corresponding sam-
p旭es ｪFigure ジGｫs Name旭yp c旭ots from warfarinized p旭asma appeared 
denserp whi旭e c旭ots from p旭asma spiked with enoxaparin were 旭ooser 
ｪFigure ズG､Lｫs C旭ots of p旭asma spiked with rivaroxabanp formed with 
TFp had increased fiber diameter size ｪゲグ芦 ± 10 nm; P < sグゲｫ when 
compared to contro旭 ｪゾザ ± ゾ nmｫ ｪFigure ズMｫs Increased fiber size for 
rivaroxaban c旭ots corre旭ated to their reduced densityp observed by 
confoca旭 microscopy ｪFigure ザGｫs Furthermorep warfarinized p旭asma 
produced c旭ots with decreased fiber size fo旭旭owing c旭otting initiation 
with thrombin ｪINR ゴsゴp 芦ザ ± 3 nm; P < sグズq and INR ジsゲp 芦ズ ± ゾq 
P < sグズｫ re旭ative to contro旭 ｪ芦芦 ± ズ nmｫ ｪFigure ズNｫs This observation 
a旭so corre旭ated with the increased c旭ot density for both warfarinized 
p旭asma samp旭esp described above ｪFigure ジGｫs
ジ科 |科DISCUSSION
Our study provides a nove旭 systematic and comprehensive direct 
comparison of a旭terations on fibrin c旭ot structurep caused by differ-
ent c旭asses of anticoagu旭antsp detected with an array of different 
sensitive methodss In agreement with previous studies on changes in 
c旭ot structure by VKAspゴゾ we find that the effects of anticoagu旭ants 
on c旭ot structure is high旭y dependent on the agonist used to initiate 
c旭ottings The mode of action of each anticoagu旭ant used in this study 
is high旭ighted in a coagu旭ation cascade schematic in the supp旭emen-
tary data ｪFigure Sゼｫs A summary of the observed changes in c旭ot 
structure parameters fo旭旭owing c旭otting with either TF or thrombin 
is shown in Tab旭e ゴs
Triggering c旭otting with TF or thrombin distinct旭y impacted on 
the structure of c旭ots formed with warfarinized p旭asma samp旭es and 
p旭asma containing direct FXa inhibitors or LMWHs Most striking is 
the fact that the most significant changes in c旭ot structure observed 
with TF were seen in the rivaroxaban c旭otsp which showed no signif-
icant changes when thrombin was useds Simi旭ar旭yp c旭otting activation 
with thrombin showed the most significant changes in enoxaparin 
c旭otsp whereas no significant changes were observed with TFs We 
hypothesize that the effects observed for enoxaparin c旭ots with 
thrombin ｪincreased 旭ag timep decreased densityp and increased po-
rosityｫ are direct旭y attributab旭e to the direct effects of this drug on 
thrombinp via interaction with antithrombins34 Indeedp the effects 
of thrombin concentration on c旭ot structurep with reduced throm-
bin concentrations generating 旭ess dense c旭ots with 旭arger poresp are 
we旭旭 known and 旭ike旭y exp旭ain these findingssゴズpザズ TF､bearing ce旭旭s 
have a旭so been shown to regu旭ate the rate of fibrin formation from 
the ce旭旭 surface through thrombin generationp modu旭ating the sta-
bi旭ity and three､dimensiona旭 structure of the c旭otsゴ葦pザ葦 In additionp 
e旭evated prothrombin concentrations have been shown to decrease 
fiber mass､to､旭ength ratio and a旭ter thrombin generationp when c旭ot-
ting initiated by TF､bearing ce旭旭ssゴズ No changes in c旭ot structure for 
the FXa inhibitors were seen with thrombinp most 旭ike旭y due to the 
fact that their mode of action is upstream and 旭arge旭y bypassed by 
the exogenous旭y added thrombins Converse旭yp TF activation is up-
stream of factor Xp a旭旭owing FXa inhibitors to demonstrate c旭ear 
effects on c旭otting activity and c旭ot structures A previous study re-
porting 旭ess dense c旭ots produced by endothe旭ia旭 ce旭旭s fo旭旭owing in-
hibition of TF activity further demonstrates the active ro旭e of TF on 
impacting c旭ot structures37 We conc旭ude from this study that c旭otting 
initiation with TF provides more accurate depictions of the effects 
of DOACs and VKA on c旭ot structurep corroborating previous re-
portss Effects of LMWH on c旭ot structurep howeverp are sensitive旭y 
detected with thrombins Interesting旭yp native TEG resu旭ts showed 
the most significant changes for both rivaroxaban and enoxaparin 
c旭otss In the absence of a triggerp and in the presence of ca旭ciump 
the intrinsic pathway eventua旭旭y 旭eads to thrombin generation and 
c旭ot formations This a旭ternative c旭ot formation pathway to the ones 
targeted by the other triggers used in this studyp supports the TEG 
findings and p旭aces further emphasis on the importance of c旭otting 
trigger se旭ection when investigating c旭ot structures
Dosages of anticoagu旭ants were chosen to ref旭ect treatment 
旭eve旭sp with the exception of enoxaparin for which the prophy旭actic 
dose was chosen due to the fact that therapeutic concentrations of 
enoxaparin ｪequiva旭ent to グsズ､ゲsグ anti､FXa U｠mL bidai旭y or ゲsグ､ゴsグ 
anti､FXa U｠mL once dai旭yｫザ芦 had such potent effects on c旭ot struc-
ture as to impair ana旭ysis ｪSupp旭ementary Tab旭e Sゲｫs We a旭so ob-
served that c旭ot structure was inf旭uenced by different 旭eve旭s of VKAs 
This study suggests that c旭ot structure ana旭ysis techniquesp such as 
permeation and turbidityp have the potentia旭 to be used to assess the 
effects of anticoagu旭ation drugs on patient c旭ot phenotypes
Apparent discrepancies in data obtained by different method-
o旭ogies may be attributed to the physica旭 state of the c旭otp name旭yp 
hydrated fu旭旭y po旭ymerized c旭ots ｪconfoca旭 and permeationｫp pro-
cessed fu旭旭y po旭ymerized c旭ots ｪSEMｫ and hydrated po旭ymerizing 
c旭ots ｪturbidityｫs From thisp we conc旭ude that data obtained from 
the different methodo旭ogies used to investigate c旭ot structure 
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are most旭y comp旭ementaryp with different structura旭 properties 
such as permeabi旭ity and fiber thickness being measured by each 
methods Our study has a number of 旭imitationss The potentia旭 c旭in-
ica旭 app旭ication of these finding wi旭旭 need to be further assessed in 
future c旭inica旭 studies using patient samp旭ess A second 旭imitation 
of this study was that confoca旭 and SEM ana旭yses were not per-
formed in a b旭inded manner to e旭iminate any potentia旭 unconscious 
biass A third 旭imitation is the use of a PP spiked with anticoagu旭ants 
rather than patient p旭asmap as patients requiring anticoagu旭ation 
have a prothrombotic c旭ot phenotype that is not ref旭ective of the 
wnorma旭x c旭ot phenotypes A future comparison between pre､ and 
post､anticoagu旭ation in patient p旭asma wou旭d provide further 
assessment of impact different anticoagu旭ants have on c旭ot pa-
rameters re旭evant to c旭inica旭 practicep and whether anticoagu旭ant 
treatment is ab旭e to revert a prothrombotic c旭ot phenotype to a 
norma旭 c旭ot phenotypes Neverthe旭essp the PP used as a contro旭 in 
this study was obtained from a 旭arge number of individua旭s before 
they underwent a range of surgica旭 proceduress It therefore in-
c旭udes individua旭s with and without under旭ying hea旭th conditionsp 
which indicates that this PP is not entire旭y norma旭p as a旭so indi-
cated by a s旭ight旭y above norma旭 average fibrinogen concentrations 
Future studies with patient p旭asma wou旭d he旭p to identify the best 
g旭oba旭 c旭ot structure methodp for instancep permeation or turbid-
ityp which do not require specia旭ist equipment and provide quan-
titative data in just a few hoursp with the potentia旭 to become a 
screening test for changes in c旭ot structures
Further 旭imitations of the study inc旭ude the use of a sing旭e con-
centration of c旭otting agonists and DOACss In vivop the concentra-
tion of free thrombin changes over the course of c旭ot formation 
and thrombin concentration has been shown to direct旭y inf旭uence 
c旭ot structurep inc旭uding fiber thickness and c旭ot densitysゴズpゴ葦pザズpザ葦 
Future studies corre旭ating thrombin generation and c旭ot structure 
wou旭d add va旭ue to the findings of this studys In additionp future 
investigations into the effect of different DOAC concentrations 
on a旭旭eviating prothrombotic c旭ot phenotype cou旭d he旭p determine 
a dosage to effect thresho旭d for these drugss Another 旭imitation 
of the study was the fact thatp due to warfarinvs mode of actionp 
this cou旭d not be spiked into the same contro旭 PP as the other an-
ticoagu旭ants and was instead obtained from individua旭s treated 
with warfarins We recognize that the PP from the two groups of 
patients on warfarin may have different properties than the PP 
used as a contro旭s Howeverp by matching the samp旭esv fibrinogen 
concentrationp which is known to inf旭uence c旭ot structure as we旭旭 
as feasib旭y possib旭ep we ensured that the best possib旭e comparison 
could be achieved.
In summaryp we have shown that c旭ot structure is significant旭y 
a旭tered by different anticoagu旭ants using an array of techniques and 
direct in vitro comparisonss In agreement with previous reportsp our 
data show that the choice of trigger for c旭otting is important when 
investigating c旭ot structure in samp旭es containing different types of 
anticoagu旭antsp with TF providing the most sensitive and accurate 
comparisons for the DOACs used in this studys Further studies are 
required to estab旭ish how these methods may contribute to a cor-
re旭ation of c旭ot structure with c旭inica旭 data either at the start of anti-
coagu旭ation or over the course of treatments Identifying changes in 
c旭ot phenotype using c旭ot structure measurementsp such as perme-
ation and turbidityp cou旭d u旭timate旭y he旭p in the prevention of b旭eed-
ing as we旭旭 as thrombotic eventss
F I G U R E  ズ 科 Fibrin fiber size and scanning e旭ectron microscopy ｪSEMｫ images of fu旭旭y formed c旭ots fo旭旭owing c旭otting with tissue factor or 
thrombins SEM images of poo旭ed p旭asma ｪPPｫ ｪAｫp warfarin internationa旭 norma旭ized ratio ｪINRｫ ゴsゴ ｪBｫp warfarin INR ジsゲ ｪCｫp PP + rivaroxaban 
ｪDｫp PP + apixaban ｪEｫp and PP + enoxaparin ｪFｫ c旭ots fo旭旭owing c旭otting initiation with tissue factors SEM images of PP ｪGｫp warfarin INR ゴsゴ 
ｪHｫp warfarin INR ジsゲ ｪIｫp PP + rivaroxaban ｪJｫp PP + apixaban ｪKｫp and PP + enoxaparin ｪLｫ c旭ots fo旭旭owing c旭otting initiation with thrombins 
Images are a representation of one of three repeatss Sca旭e bar represents ズ μms Fiber size was measured from SEM imagesp each imaged in 
three different areas of the c旭otp at ゲグ グググx magnification fo旭旭owing c旭otting activation by tissue factor ｪMｫ and thrombin ｪNｫs Each data point 
corresponds to individua旭 measurements of three rep旭icatess Error bars correspond to ± SEs ｰP < sグズp ｰｰP < .01
TA B L E  ゴ 科 Summary of changes in c旭ot structure parameters fo旭旭owing c旭otting with tissue factor or thrombin
Tissue factor Thrombin
Wars ゴsゴ Wars ジsゲ Rivaroxs Apixs Enoxs Wars ゴsゴ Wars ジsゲ Rivaroxs Apixs Enoxs
MaxOD - - - - - - - - - -
Lag time ┢ ┢ ┢ ┢ - - - - - ┢
Avs Rate ┣ ┣ - - - - ┣ - - -
Fiber density - ┣ ┣ ┣ - ┢ ┢ ┣
Pore size - - ┢ ┢ - - - - - ┢
Fiber size - - ┢ - - ┣ ┣ - - -
Note: ､ no significant changeq ┢ significant increasep P └ sグズq ┣ significant decreasep P └ sグズs
Abbreviationr MaxODp maximum absorbances
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